in addition , they suggest incomplete cross-resistance between doxorubicin and menogaril and , considering the concentrations of n-demethylmenogaril in animals and humans , a minor role for this metabolite in the overall antitumor activity of the parent compound .
C0376622
resistance
C0086418
humans